Rating History for CRISPR Therapeutics (CRSP) by Evercore ISI

More Stocks Rated by Evercore ISI | Latest Ratings for CRSP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/13/2026 Liisa Bayko Maintain Outperform
(N/A)		 74.00
(62.00)		  
 		   Details